Crossref
262 Comparison of Psychiatric Readmission Rates Following Discharge on Long-Acting Injectable Antipsychotics
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103290
DOI: 10.1016/j.japh.2026.103290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von Y. Sun und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sun, Y., Jun, M., & Park, S. (2026). 262 Comparison of Psychiatric Readmission Rates Following Discharge on Long-Acting Injectable Antipsychotics. Journal of the American Pharmacists Association, 66(4), 103290. https://doi.org/10.1016/j.japh.2026.103290
Vancouver
Sun Y, Jun M, Park S. 262 Comparison of Psychiatric Readmission Rates Following Discharge on Long-Acting Injectable Antipsychotics. Journal of the American Pharmacists Association. 2026;66(4):103290. doi:10.1016/j.japh.2026.103290
BibTeX
@article{Sun2026,
author = {Sun, Y. and Jun, M. and Park, S.},
title = {262 Comparison of Psychiatric Readmission Rates Following Discharge on Long-Acting Injectable Antipsychotics},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103290},
doi = {10.1016/j.japh.2026.103290}
}
EUVIMED